Stock 3MP MERRION PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Merrion Pharmaceuticals Plc

Equities

3MP

IE00B282VY28

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Merrion Pharmaceuticals : Notice of General meetings
PU
Merrion Pharmaceuticals : Proposed liquidation
PU
Merrion Pharmaceuticals : Disposal Completion
PU
Merrion Pharmaceuticals : Interim results for the six month period ended 30 June 2015, Dublin, Ireland 30 September 2015
PU
Merrion Pharmaceuticals : Announces Continuing Progress of Oral Insulin Projects Using Merrion Pharmaceuticals' GIPET Technology under license to its partner Novo Nordisk A/S
PU
Merrion Pharmaceuticals : Annual Report and Notice of AGM
PU
Merrion Pharmaceuticals : Annual Report
PU
Merrion Pharmaceuticals : Announces Completion of Disposal of Citywest Facility
PU
Merrion Pharmaceuticals : "Merrion" or the "Company") announces the proposed disposal of its Citywest facility for a consideration of €2,175,000
PU
Merrion Pharmaceuticals : Receives Milestone Payment Following Successful Completion of a Phase I Study of Novo Nordisk A/S Oral GLP-1 Analogue (NN9928) Using Merrion Pharmaceuticals' GIPET Technology
PU
Merrion Pharmaceuticals : Hovione and Merrion Pharmaceuticals Announce Strategic Partnership on Use of Merrion's GIPET Technology
PU
Merrion Pharmaceuticals : Directorate Change
PU
Merrion Pharmaceuticals : Annual Report and Notice of AGM and EGM
PU
Merrion Pharmaceuticals' : GIPET Technology Progresses with Novo Nordisk Oral Insulin Development
PU
Merrion Pharmaceuticals : FDA meeting clears way for MER-101 in treatment of early breast cancer
PU
Merrion Pharmaceuticals Plc : Novo Nordisk A/S Successfully Completes Phase I Trial of its Proprietary Oral Insulin (NN1956) using Merrion Pharmaceuticals' GIPET® Technology.
PU
Merrion Pharmaceuticals Plc : Appointment of Director
PU
Merrion Pharmaceuticals Plc : Appointment of CEO and Chairman
PU
Merrion Pharmaceuticals Plc : Interim Results for the Six Months Ended 30 June 2013
PU
Merrion Pharmaceuticals Plc : Result of AGM
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3MP Stock
  4. News Merrion Pharmaceuticals Plc